News from August 2013
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (16)
Three works led by the ICREA investigator Dr. Josep Dalmau among the 25 Lancet Neurology most cited papers
Dr. Josep Dalmau is an ICREA investigator leading the IDIBAPS Autoimmunity against synaptic antigens Group. His international impact is reflected in1
Early treatment of patients with asymptomatic myeloma delays disease progression
Early treatment of asymptomatic high-risk smoldering myeloma could significantly improve the course of disease, slowing its progression and significa1